Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Statement on safety of cannabidiol as a novel food: data gaps and uncertainties

Autor: Turck, Dominique, Bohn, Torsten, Castenmiller, Jacqueline, De Henauw, Stefaan, Hirsch-Ernst, Karen Ildico, Maciuk, Alexandre, Mangelsdorf, Inge, McArdle, Harry J., Naska, Androniki, Pelaez, Carmen, Pentieva, Kristina, Siani, Alfonso, Thies, Frank, Tsabouri, Sophia, Vinceti, Marco, Cubadda, Francesco, Frenzel, Thomas, Heinonen, Marina, Marchelli, Rosangela, Neuhaeuser-Berthold, Monika, Poulsen, Morten, Maradona, Miguel Prieto, Schlatter, Josef Rudolf, Trezza, Viviana, van Loveren, Henk, Albert, Oceane, Dumas, Celine, Germini, Andrea, Gelbmann, Wolfgang, Kass, Georges, Kouloura, Eirini, Fernandez, Estefania Noriega, Rossi, Annamaria, Knutsen, Helle Katrine, Nutr Novel Foods Food, EFSA Panel

Publikováno v: EFSA JOURNAL

The European Commission has determined that cannabidiol (CBD) can be considered as a novel food (NF), and currently, 19 applications are under assessment at EFSA. While assessing these, it has become clear that there are knowledge gaps that need to b

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1923bbee7538d604150ccb5a2ff65e94
https://hdl.handle.net/11380/1284884

Guidance on aneugenicity assessment

Autor: EFSA Scientific Committee (SC), More, Simon John, Bampidis, Vasileios, Bragard, Claude, Halldorsson, Thorhallur Ingi, Hernández-Jerez, Antonio F, Hougaard Bennekou, Susanne, Koutsoumanis, Kostas, Lambré, Claude, Machera, Kyriaki, Naegeli, Hanspeter, Nielsen, Søren Saxmose, Schlatter, Josef, Schrenk, Dieter, Turck, Dominique, Younes, Maged, Aquilina, Gabriele, Bignami, Margherita, Bolognesi, Claudia, Crebelli, Riccardo, Gürtler, Rainer, Marcon, Francesca, Nielsen, Elsa, Vleminckx, Christiane, Carfì, Maria, Martino, Carla, Maurici, Daniela, Parra Morte, Juan, Rossi, Annamaria, Benford, Diane

Publikováno v: EFSA Journal
EFSA Scientific Committee (SC) 2021, ' Guidance on aneugenicity assessment ', EFSA Journal, vol. 19, no. 8, e06770 . https://doi.org/10.2903/j.efsa.2021.6770
EFSA Journal, Vol 19, Iss 8, Pp n/a-n/a (2021)
EFSA Scientific Committee, More, S J, Bampidis, V, Bragard, C, Halldorsson, T I, Hernández-Jerez, A F, Hougaard Bennekou, S, Koutsoumanis, K, Lambré, C, Machera, K, Naegeli, H, Nielsen, S S, Schlatter, J, Schrenk, D, Turck, D, Younes, M, Aquilina, G, Bignami, M, Bolognesi, C, Crebelli, R, Gürtler, R, Marcon, F, Nielsen, E, Vleminckx, C, Carfì, M, Martino, C, Maurici, D, Parra Morte, J, Rossi, A & Benford, D 2021, ' Guidance on aneugenicity assessment ', EFSA Journal, vol. 19, no. 8, e06770, pp. 1-27 . https://doi.org/10.2903/j.efsa.2021.6770

The EFSA Scientific Committee was asked to provide guidance on the most appropriate in vivo tests to follow up on positive in vitro results for aneugenicity, and on the approach to risk assessment for substances that are aneugenic but not clastogenic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edd15ea78f24f0309a9e8a3d3bccd0f7